Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Richard A, Koup"'
Autor:
Laura L. Sutherland, Takuya Yamamoto, Barton F. Haynes, Norman L. Letvin, Madhu Prabhakaran, Wesley Hoyland, Sandeep Narpala, David J. Pickup, Steven Ma, Christopher Fletez-Brant, Mario Roederer, Sampa Santra, Adrian B. McDermott, Hua-Xin Liao, Richard A. Koup, Michelle L. Lifton, Elizabeth Ramsburg, Kristin L. Boswell, Gail Levine, Constantinos Petrovas, Leila Eslamizar, David J. Leggat, Kathryn Furr, David C. Montefiori
Publikováno v:
NPJ Vaccines
npj Vaccines, Vol 6, Iss 1, Pp 1-10 (2021)
npj Vaccines, Vol 6, Iss 1, Pp 1-10 (2021)
The RV144 HIV-1 vaccine trial has been the only clinical trial to date that has shown any degree of efficacy and associated with the presence of vaccine-elicited HIV-1 envelope-specific binding antibody and CD4+ T-cell responses. This trial also show
Autor:
Mary E. Enama, Sarah F. Andrews, Julie E. Ledgerwood, Richard A. Koup, Richard M. Schwartz, Adam DeZure, Sarah H. Plummer, Galina Yamshchikov, Ingelise J. Gordon, Emily E. Coates, Michelle C. Crank, John R. Mascola, Terrence M. Tumpey, Xiangjie Sun, Barney S. Graham, Kathryn L Zephir, Adrian B. McDermott, Zonghui Hu, Florence Kaltovich, Robert T. Bailer
Publikováno v:
npj Vaccines, Vol 2, Iss 1, Pp 1-6 (2017)
NPJ Vaccines
npj Vaccines
NPJ Vaccines
npj Vaccines
A novel avian influenza subtype, A/H7N9, emerged in 2013 and represents a public health threat with pandemic potential. We have previously shown that DNA vaccine priming increases the magnitude and quality of antibody responses to H5N1 monovalent ina